![Lorianne K. Masuoka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lorianne K. Masuoka
Directeur Technique/Scientifique/R&D chez DIAMEDICA THERAPEUTICS INC.
Fortune : - $ au 31/05/2024
Postes actifs de Lorianne K. Masuoka
Sociétés | Poste | Début | Fin |
---|---|---|---|
DIAMEDICA THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 22/01/2024 | - |
Historique de carrière de Lorianne K. Masuoka
Anciens postes connus de Lorianne K. Masuoka
Sociétés | Poste | Début | Fin |
---|---|---|---|
OPIANT PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 18/03/2021 | 02/03/2023 |
Independent Dir/Board Member | 18/03/2021 | 02/03/2023 | |
PFENEX INC. | Directeur/Membre du Conseil | 07/08/2019 | 01/10/2020 |
Independent Dir/Board Member | 07/08/2019 | 01/10/2020 | |
MARINUS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 11/04/2017 | 31/10/2019 |
INVIVO THERAPEUTICS HOLDINGS CORP. | Directeur Technique/Scientifique/R&D | 01/03/2015 | 02/01/2017 |
CUBIST PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 08/07/2013 | 01/01/2015 |
NEKTAR THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2008 | 01/01/2011 |
FIVE PRIME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2003 | 01/08/2008 |
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2000 | 01/01/2003 |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Lorianne K. Masuoka
University of California, Davis | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
Allemagne | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 11 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
MARINUS PHARMACEUTICALS, INC. | Health Technology |
DIAMEDICA THERAPEUTICS INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Five Prime Therapeutics, Inc.
![]() Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Berlex Laboratories, Inc. | |
Pelican Inc
![]() Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Bayer Schering Pharma AG | Health Technology |
Opiant Pharmaceuticals, Inc.
![]() Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Bourse
- Insiders
- Lorianne K. Masuoka
- Expérience